azomycin has been researched along with hydroxymethylnitrofurazone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BasombrÃo, MA; Chung, MC; Davies, C; Marino Cardozo, R; Mora, MC; Sánchez Negrette, O | 1 |
| Basombrio, MA; Davies, C; Dey, N; Garg, NJ; Negrette, OS; Parada, LA | 1 |
| Chin, CM; da Rosa, JA; de Andrade, CR; Dos Santos, JL; Scarim, CB | 1 |
3 other study(ies) available for azomycin and hydroxymethylnitrofurazone
| Article | Year |
|---|---|
Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease.
Topics: Animals; Chagas Disease; Female; Liver; Mice; Molecular Structure; Muscle, Skeletal; Nitrofurazone; Nitroimidazoles; Polymerase Chain Reaction; Random Allocation; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethylnitrofurazone: a comparison with Benznidazole.
Topics: Animals; Cell Death; Cell Line, Tumor; Chagas Disease; Chemical and Drug Induced Liver Injury; DNA Damage; Female; Hep G2 Cells; Humans; Liver; Male; Mice; Mitochondria; Nifurtimox; Nitrofurazone; Nitroimidazoles; Parasites; Reactive Oxygen Species; Trypanocidal Agents; Trypanosoma cruzi; Tumor Necrosis Factor-alpha; Tyrosine | 2014 |
Hydroxymethylnitrofurazone treatment in indeterminate form of chronic Chagas disease: Reduced intensity of tissue parasitism and inflammation-A histopathological study.
Topics: Animals; Chagas Disease; Disease Models, Animal; Inflammation; Kidney; Liver; Male; Mice; Muscle, Skeletal; Nitrofurazone; Nitroimidazoles; Trypanosoma cruzi | 2018 |